160 related articles for article (PubMed ID: 12191821)
1. The selective serotonin(1A)-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase.
Müller CP; De Souza Silva MA; DePalma G; Tomaz C; Carey RJ; Huston JP
Behav Brain Res; 2002 Aug; 134(1-2):337-46. PubMed ID: 12191821
[TBL] [Abstract][Full Text] [Related]
2. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation.
Müller CP; Carey RJ; De Souza Silva MA; Jocham G; Huston JP
Synapse; 2002 Aug; 45(2):67-77. PubMed ID: 12112399
[TBL] [Abstract][Full Text] [Related]
3. The 5-HT(1A) antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine.
Carey R; Damianopoulos E; DePalma G
Brain Res; 2000 Apr; 862(1-2):242-6. PubMed ID: 10799692
[TBL] [Abstract][Full Text] [Related]
4. Cocaine and serotonin: a role for the 5-HT(1A) receptor site in the mediation of cocaine stimulant effects.
Carey RJ; DePalma G; Damianopoulos E
Behav Brain Res; 2001 Nov; 126(1-2):127-33. PubMed ID: 11704258
[TBL] [Abstract][Full Text] [Related]
5. Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study.
Müller CP; Carey RJ; Salloum JB; Huston JP
Neuropharmacology; 2003 Apr; 44(5):592-603. PubMed ID: 12668045
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms.
Carey RJ; De Palma G; Damianopoulos E
Behav Brain Res; 2002 Apr; 132(1):37-46. PubMed ID: 11853856
[TBL] [Abstract][Full Text] [Related]
7. 8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol.
Carey R; Damianopoulos E; De Palma G
Pharmacol Biochem Behav; 2000 Aug; 66(4):863-72. PubMed ID: 10973527
[TBL] [Abstract][Full Text] [Related]
8. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
Kosten TA; Zhang XY; Kehoe P
J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
[TBL] [Abstract][Full Text] [Related]
10. 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine.
Frantz KJ; Hansson KJ; Stouffer DG; Parsons LH
Neuropharmacology; 2002 Feb; 42(2):170-80. PubMed ID: 11804613
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine.
Essman WD; Singh A; Lucki I
Pharmacol Biochem Behav; 1994 Sep; 49(1):107-13. PubMed ID: 7816859
[TBL] [Abstract][Full Text] [Related]
12. Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.
Kannari K; Yamato H; Shen H; Tomiyama M; Suda T; Matsunaga M
J Neurochem; 2001 Mar; 76(5):1346-53. PubMed ID: 11238719
[TBL] [Abstract][Full Text] [Related]
13. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
14. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat.
Bonhomme N; De Deurwaèrdere P; Le Moal M; Spampinato U
Neuropharmacology; 1995 Mar; 34(3):269-79. PubMed ID: 7543190
[TBL] [Abstract][Full Text] [Related]
15. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects.
Carey RJ; DePalma G; Damianopoulos E; Shanahan A; Müller CP; Huston JP
Brain Res; 2005 Feb; 1034(1-2):162-71. PubMed ID: 15713268
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens.
McNeish CS; Svingos AL; Hitzemann R; Strecker RE
Pharmacol Biochem Behav; 1993 Aug; 45(4):759-63. PubMed ID: 8415815
[TBL] [Abstract][Full Text] [Related]
19. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.
De Deurwaerdère P; Spampinato U
J Neurochem; 1999 Sep; 73(3):1033-42. PubMed ID: 10461892
[TBL] [Abstract][Full Text] [Related]
20. Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.
Willins DL; Meltzer HY
Brain Res; 1998 Jan; 781(1-2):291-9. PubMed ID: 9507167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
